Latest Breaking News On - Variants program - Page 1 : comparemela.com

<p>A new study by investigators from <a href="https://www.massgeneralbrigham.org/">Mass General Brigham</a> found that one in five individuals taking Nirmatrelvir-ritonavir therapy, commonly known as Paxlovid, to treat severe symptoms of COVID-19, experienced a positive test result and shedding of live and potentially contagious virus following an initial recovery and negative test&mdash;a phenomenon known as virologic rebound. By contrast, people not taking Paxlovid only experienced rebound about 2 percent of the time. Results are published in <a href="https://www.acpjournals.org/journal/aim/authors1"><em>Annals of Internal Medicine</em></a>.</p>

Harvard universityUnited statesShruti sagarManishc choudharySarahp hammondMark siednerMamadou barryYumeko kawanoZachary wallaceRockib uddinGregorye edelsteinJacobe lemieuxDessie tienRebeccaf gilbertJonathon liZahra reynolds